Literature DB >> 33574248

Renal metabolism and hypertension.

Zhongmin Tian1, Mingyu Liang2.   

Abstract

Hypertension is a leading risk factor for disease burden worldwide. The kidneys, which have a high specific metabolic rate, play an essential role in the long-term regulation of arterial blood pressure. In this review, we discuss the emerging role of renal metabolism in the development of hypertension. Renal energy and substrate metabolism is characterized by several important and, in some cases, unique features. Recent advances suggest that alterations of renal metabolism may result from genetic abnormalities or serve initially as a physiological response to environmental stressors to support tubular transport, which may ultimately affect regulatory pathways and lead to unfavorable cellular and pathophysiological consequences that contribute to the development of hypertension.

Entities:  

Year:  2021        PMID: 33574248     DOI: 10.1038/s41467-021-21301-5

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  123 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Blood pressure control--special role of the kidneys and body fluids.

Authors:  A C Guyton
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

3.  On getting there from here.

Authors:  Steven L McKnight
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

Review 4.  The role of the kidney in hypertension.

Authors:  A W Cowley; R J Roman
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

Review 5.  Metabolic remodelling in heart failure.

Authors:  Edoardo Bertero; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

6.  [Fat embolism with special reference to its cerebral form].

Authors:  F Stancić-Rokotov
Journal:  Lijec Vjesn       Date:  1966-05

7.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

8.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study.

Authors:  L J Launer; K Masaki; H Petrovitch; D Foley; R J Havlik
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

Review 9.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

10.  Ushering Hypertension Into a New Era of Precision Medicine.

Authors:  Theodore A Kotchen; Allen W Cowley; Mingyu Liang
Journal:  JAMA       Date:  2016-01-26       Impact factor: 56.272

View more
  14 in total

1.  Substrate-dependent differential regulation of mitochondrial bioenergetics in the heart and kidney cortex and outer medulla.

Authors:  Namrata Tomar; Xiao Zhang; Sunil M Kandel; Shima Sadri; Chun Yang; Mingyu Liang; Said H Audi; Allen W Cowley; Ranjan K Dash
Journal:  Biochim Biophys Acta Bioenerg       Date:  2021-12-03       Impact factor: 3.991

Review 2.  Targeting fatty acid metabolism for fibrotic disorders.

Authors:  Seonghwan Hwang; Ki Wung Chung
Journal:  Arch Pharm Res       Date:  2021-10-18       Impact factor: 4.946

3.  Momordica charantia Extract Confers Protection Against Hypertension in Dahl Salt-Sensitive Rats.

Authors:  Li Zeng; Meng Chen; Hussain Ahmad; Xuewei Zheng; Yanan Ouyang; Pengfei Yang; Zhe Yang; Di Gao; Zhongmin Tian
Journal:  Plant Foods Hum Nutr       Date:  2022-06-16       Impact factor: 4.124

Review 4.  The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development.

Authors:  Tomohito Doke; Katalin Susztak
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

5.  3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy.

Authors:  Jeeyoun Jung; Woo Yeong Park; Yun Jin Kim; Mikyung Kim; Misun Choe; Kyubok Jin; Ji Hae Seo; Eunyoung Ha
Journal:  Antioxidants (Basel)       Date:  2022-02-14

6.  Transfer RNA Fragments in the Kidney in Hypertension.

Authors:  Xiaoqing Pan; Xuemei Geng; Yong Liu; Mengqian Yu; Manoj K Mishra; Xialian Xu; Xiaoqiang Ding; Pengyuan Liu; Mingyu Liang
Journal:  Hypertension       Date:  2021-03-29       Impact factor: 10.190

7.  Substrate- and Calcium-Dependent Differential Regulation of Mitochondrial Oxidative Phosphorylation and Energy Production in the Heart and Kidney.

Authors:  Xiao Zhang; Namrata Tomar; Sunil M Kandel; Said H Audi; Allen W Cowley; Ranjan K Dash
Journal:  Cells       Date:  2021-12-31       Impact factor: 7.666

Review 8.  Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.

Authors:  Hui-Qing Chen; Jin-Yu Gong; Kai Xing; Mou-Ze Liu; Huan Ren; Jian-Quan Luo
Journal:  Front Med (Lausanne)       Date:  2022-01-19

9.  The association between bilirubin and hypertension among a Chinese ageing cohort: a prospective follow-up study.

Authors:  Chen Tang; Hanxiang Jiang; Bin Zhao; Yi Lin; Shengnan Lin; Tianmu Chen; Yanhua Su; Yiqin Zhang; Lina Zhou; Lianmeng Li; Jincheng Lin; Zhonghua Lu; Yao Wang; Zeyu Zhao; Longjian Liu; Yuxin Wang; Jie Zhang; Heqing Shen
Journal:  J Transl Med       Date:  2022-03-04       Impact factor: 5.531

Review 10.  miR-204: Molecular Regulation and Role in Cardiovascular and Renal Diseases.

Authors:  Jing Liu; Yong Liu; Feng Wang; Mingyu Liang
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.